Design of Intramolecularly Activated Prodrugs

References

• Testa B. The Metabolism of Drugs and Other Xenobiotics—Biochemistry of Redox Reactions. Academic Press, London 1995, Sect. 1.8
   Google Scholar
• Harper N. J. Drug latentiation. Progress in Drug Research, E. Jucker. Birkhäuser, Basel 1962; Vol. 4: 221–294
   Google Scholar
• Stella V. J., Charman W. N. A., Naringrekar V. H. Prodrugs: Do they have advantages in clinical practice?. Drugs 1985; 29: 455–473
   PubMed Web of Science ®Google Scholar
• Optimization of Drug Delivery, H. Bundgaard, A. B. Hansen, H. Kofod. Munkgaard, Copenhagen 1982
   Google Scholar
• Directed Drug Delivery—A Multidisciplinary Approach, R. T. Borchardt, A. J. Repta, V. J. Stella. Humana Press, Totowa, NJ 1985
   Google Scholar
• Wermuth C. G. Designing prodrugs and bioprecursors. Drug Design: Fact or Fantasy?, G. Jolles, K. R. H. Woolridge. Academic Press, London 1984; 47–72
   Google Scholar
• Drug and Enzyme Targeting. Methods in Enzymology, K. J. Widder, R. Green. Academic Press, Orlando, FL 1985; Volume 112
   Google Scholar
• Chan S. Y., Li Wan Po A. Prodrugs for dermal delivery. Int. J. Pharmaceut. 1989; 55: 1–16
   Web of Science ®Google Scholar
• Waller D. G., George C. F. Prodrugs. Br. J. Clin. Pharmacol. 1989; 28: 497–507
   PubMed Web of Science ®Google Scholar
• Gangwar S., Pauletti G. M., Wang B., Siahaan T. J., Stella V. J., Borchardt R. T. Prodrug strategies to enhance the intestinal absorption of peptides. Drug Discov. Today 1997; 2: 148–155
   Web of Science ®Google Scholar
• Testa B. Drug metabolism. Burger's Medicinal Chemistry and Drug Discovery, 5th ed., M. E. Wolff. Wiley, New York 1995; Vol. 1: 129–180
   Google Scholar
• Balant L. P., Doelker E. Metabolic considerations in prodrug design. Burger's Medicinal Chemistry and Drug Discovery, 5th ed., M. E. Wolff. Wiley, New York 1995; Vol. 1: 949–982
   Google Scholar
• Testa B., Caldwell J. Prodrugs revisited-The “ad hoc” approach as a complement to ligand design. Med. Res. Rev. 1996; 16: 233–241
   PubMed Web of Science ®Google Scholar
• Page M. I., Render D., Bernath G. Stereochemical studies. Part 112. Geometrical dependence of intramolecular catalysis in the hydrolysis and aminolysis of aryl esters. J. Chem. Soc. Perkin Trans. 1986; 11: 867–871
   Google Scholar
• Bundgaard H., Larsen C., Arnold E. Prodrugs as drug delivery systems XXVII. Chemical stability and bioavailability of a water-soluble prodrug of metronidazole for parenteral administration. Int. J. Pharmaceut. 1984; 18: 79–87
   Web of Science ®Google Scholar
• Wernly-Chung G. N., Mayer J. M., Tsantili-Kakoulidou A., Testa B. Structure-reactivity relationships in the chemical hydrolysis of prodrug esters of nicotinic acid. Int. J. Pharmaceut. 1990; 63: 129–134
   Web of Science ®Google Scholar
• Shan D., Nicolaou M. G., Borchardt R. T., Wang B. Prodrug strategies based on intramolecular cyclization reactions. J. Pharm. Sci. 1997; 86: 765–767
   PubMed Web of Science ®Google Scholar
• Saari W. S., Schwering J. E., Lyle P. A., Smith S. J., Engelhardt E. L. Cyclization-activated prodrugs. Basic esters of 5-bromo-2α-deoxyuridine. J. Med. Chem. 1990; 33: 2590–2595
   PubMed Web of Science ®Google Scholar
• Saari W. S., Schwering J. E., Lyle P. A., Smith S. J., Engelhardt E. L. Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole. J. Med. Chem. 1990; 33: 97–101
   PubMed Web of Science ®Google Scholar
• Thomsen K. F., Strøm F., Sforzini B. V., Begtrup M., Mørk N. Evaluation of phenyl carbamates of ethyl diamines as cyclization–activated prodrug forms for protecting phenols against first-pass metabolism. Int. J. Pharmaceut. 1994; 112: 143–152
   Web of Science ®Google Scholar
• Thomsen K. F., Bundgaard H. Cyclization-activated phenyl carbamate prodrug forms for protecting phenols against first-pass metabolism. Int. J. Pharmaceut. 1993; 91: 39–49
   Web of Science ®Google Scholar
• Fredholt K., Mork N., Begtrup M. Hemiesters of aliphatic dicarboxylic acids as cyclization-activated prodrug forms for protecting phenols against first-pass metabolism. Int. J. Pharmaceut. 1995; 123: 209–216
   Web of Science ®Google Scholar
• Vigroux A., Bergon M., Zedde C. Cyclization-activated prodrugs: N-(Substituted 2-hydroxyphenyl and 2-hydroxypropyl)carbamates based on ring-opened derivatives of active benzoxazolones and oxazolidinones as mutual prodrugs of acetaminophen. J. Med. Chem. 1995; 38: 3983–3994
   PubMed Web of Science ®Google Scholar
• Bundgaard H., Falch E., Larsen C., Mosher G. L., Mikkelson T. J. Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters. J. Pharm. Sci. 1986; 75: 775–783
   PubMed Web of Science ®Google Scholar
• Nielsen N. M., Bundgaard H. Prodrugs as drug delivery systems. 42. 2-Hydroxymethylbenzamides and 2-acyloxymethylbenzamides as potential prodrug forms for amines. Int. J. Pharmaceut. 1986; 29: 9–18
   Web of Science ®Google Scholar
• Amsberry K. L., Gerstenberger A. E., Borchardt R. T. Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug. Pharm. Res. 1991; 8: 455–461
   PubMed Web of Science ®Google Scholar
• Wang B., Zhang H., Wang W. Chemical feasibility studies of a potential coumarin-based prodrug system. Bioorg. Med. Chem. Lett. 1996; 6: 945–950
   Web of Science ®Google Scholar
• Pauletti G. M., Gangwar S., Wang B., Borchardt R. T. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of a phenylpropionic acid promoiety in a model hexapeptide. Pharm. Res. 1997; 14: 11–17
   PubMed Web of Science ®Google Scholar
• Wang B., Wang W., Zhang H., Shan D., Smith T. D. Coumarin-based prodrugs 2. Synthesis and bioreversibility studies of an esterase-sensitive cyclic prodrug of DADLE, an opioid peptide. Bioorg. Med. Chem. Len. 1996; 6: 2823–2826
   Web of Science ®Google Scholar
• Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997; 23: 3–25
   Web of Science ®Google Scholar
• Testa B., Mayer J. M. Hydrolysis in Drug and Prodrug Metabolism—The Biochemistry and Enzymology of Hydrolases. Verlag Helvetica Chimica Acta, (in press)
   Google Scholar